Abstract
Minimum inhibitory concentrations of seven new β-lactam derivatives were determined against 35 isolates of Yersinia enterocolitica. Ceftizoxime and ceftriaxone were the most active of the antimicrobial agents tested.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fallon R. J. Yersinia enterocolitica epidemiology and antibiotic susceptibility. J Antimicrob Chemother. 1979 May;5(3):241–244. doi: 10.1093/jac/5.3.241. [DOI] [PubMed] [Google Scholar]
- Hammerberg S., Sorger S., Marks M. I. Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3. Antimicrob Agents Chemother. 1977 Mar;11(3):566–568. doi: 10.1128/aac.11.3.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kohl S., Jacobson J. A., Nahmias A. Yersinia enterocolitica infections in children. J Pediatr. 1976 Jul;89(1):77–79. doi: 10.1016/s0022-3476(76)80932-8. [DOI] [PubMed] [Google Scholar]
- Mollaret H. H., Bercovier H., Alonso J. M. Summary of the data received at the WHO Reference Center for Yersinia enterocolitica. Contrib Microbiol Immunol. 1979;5:174–184. [PubMed] [Google Scholar]
- Raevuori M., Harvey S. M., Pickett M. J., Martin W. J. Yersinia enterocolitica: in vitro antimicrobial susceptibility. Antimicrob Agents Chemother. 1978 May;13(5):888–890. doi: 10.1128/aac.13.5.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verbist L. Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli. Antimicrob Agents Chemother. 1981 Mar;19(3):407–413. doi: 10.1128/aac.19.3.407. [DOI] [PMC free article] [PubMed] [Google Scholar]